BOMBERG
15.7.2021 11:14:08 CEST | Business Wire | Press release
True to its rebellious spirit, BOMBERG has launched the first watch ever to incorporate CBD leaves extract: "BB01 Automatic Cure the BullDog ".
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210715005041/en/
BOMBERG connections to CBD are rooted in the relationship nurtured over the years with dogs.
Since the BOMBERG launch in 2012 the bulldogs, Bolt in Mexico and Duke & Paulina in Switzerland, have always been the official brand ambassadors and mascot.
In 2015 BOMBERG partnered with “Barry Foundation ”, the world’s oldest breeder of St. Bernards and in 2020 with the campaign “Take care of me” supported the “Black Jaguar-White Tiger Foundation ”.
After Bolt suffered an episode of stress, BOMBERG got in touch with “Bouledogue Attitude Foundation ”, in Switzerland, that recommended CBD-based food for its natural properties that help relieve anxiety as well as create a stronger nervous system.
Bolt recovered quickly and helps now spreading the word about BB-01 Automatic Cure the BullDog , the world’s first watch ever containing 100% natural CBD with 0% THC.
Treading an unbeaten path away from the roots of traditional lifestyle industry, BOMBERG embraces the free and insurgent spirit of millions of people around the world who dare to be different and to create their own maverick rules.
The new BB01 Automatic Cure the BullDog combines BOMBERG revolutionary, free and adventurous soul with an outstanding concept and a phenomenal design.
The dial features the instantly recognisable CBD indica plant with its seven serrated leaves and a powerful Super-LumiNova that makes the watch always readable.
BB01 Automatic Cure the BullDog presents real CBD indica leaves extract inside the dial and a strap made of authentic hemp, produced by our partner in the United States, following the strictest sustainability and natural production standards.
BB-01 Automatic Cure the BullDog is the ultimate symbol of audacity signed by BOMBERG .
Technical details:
Reference: |
CT43ASS.30-1.11 |
||
Movement: |
Automatic 3 hands, Sellita SW200, 38 hours power reserve |
||
Case: |
43mm, stainless steel case |
||
|
Outer ring with CBD leaves pattern |
||
Dial: |
Strong Superluminova on the Indica leaf |
||
|
Real organic US hemp inside the dial below the Indica leaf |
||
Crystal: |
Sapphire with anti reflective coating |
||
WR: |
50m |
||
Strap: |
Fabric strap made with US hemp |
||
Buckle: |
Stainless steel folding clasp |
||
|
RRP CHF, VAT excl. CHF 1’790 |
||
|
Quantity SPECIAL EDITION with limited production |
View source version on businesswire.com: https://www.businesswire.com/news/home/20210715005041/en/
Link:
Social Media:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Alsym Energy Announces Na-Series Battery Success Developed With Physics-Informed AI Platform27.4.2026 21:25:00 CEST | Press release
Alsym’s proprietary physics-informed AI platform powered the development of its Na-Series batteries—a non-flammable, high performance and low cost energy solution positioned to serve critical energy storage markets including data centers, utilities, telecommunications, commercial real estate, industrial and defense, among others. Alsym Energy, a pioneer in non-flammable, high-performance sodium-ion batteries, today announced details of the proprietary physics-informed AI platform used to develop the company’s recently launched Na-Series sodium-ion batteries. By integrating fundamental physics models with AI, autonomous testing and proprietary molecular diagnostics in a closed-loop system, Alsym is accelerating the design of safer, inexpensive, commercialized batteries through all phases of the development cycle. As global demand for electricity surges, the limitations of lithium-ion batteries have become increasingly apparent, particularly around safety and supply chain constraints. Li
Backed by Investments Exceeding $1 Billion, PCI Pharma Services Announces Major Expansion of US Sterile Fill-Finish and Drug-Device Delivery Combination Capabilities27.4.2026 16:00:00 CEST | Press release
As pharma manufacturers prioritize US supply chain resilience, highlights include high-speed isolator filling lines for prefilled syringes, cartridges and vials, and drug-device combination assembly and packaging. PCI Pharma Services (“PCI”) – a world-leading integrated global contract development and manufacturing organization (CDMO) focused on innovative biologic and small molecule therapies – announced a series of major infrastructure investments that substantially deepen its sterile fill-finish and advanced drug delivery capabilities. As pharma manufacturers and their development partners increasingly prioritize US supply chain resilience, PCI’s latest investments come as part of a broader commitment exceeding $1 billion across the CDMO’s US and European operations, reinforcing its ability to provide seamless support for drug product development and manufacturing, clinical trial supply and drug-device combination assembly from clinical stages through commercial launch – all underpi
Pure Lithium Appoints Renowned Battery Expert Dr. Yuan Gao to Board of Directors27.4.2026 15:53:00 CEST | Press release
Pure Lithium Corporation, a vertically integrated lithium metal battery technology company, is pleased to announce that world-renowned inventor and battery expert Dr. Yuan Gao has joined the company’s Board of Directors. Dr. Gao has been an invaluable member of Pure Lithium’s Scientific Advisory Board since October of 2023. "We are thrilled to have Dr. Gao join our board as we focus on rapidly scaling our technology in the most capital efficient manner possible,” said Pure Lithium Founder, Chairman and CEO Emilie Bodoin. “Dr. Gao is a brilliant scientist who also has deep commercial expertise, a rare combination. He is also unique in the industry because his experience spans the entire battery materials value chain, including all of Pure Lithium’s verticals. His insights over the years have been critical in advancing our technology, and his experience as a director of public companies will strengthen our board.” Dr. Gao commented: “I am thrilled to join the board of Pure Lithium Corpor
Taiho Oncology, Taiho Pharmaceutical and Araris Biotech AG Advance ADC ARC-02 into Phase 1 Clinical Development27.4.2026 15:00:00 CEST | Press release
Phase 1 dose-escalation trial represents the first clinical trial of a product developed using the AraLinQ™ ADC technology and marks Taiho’s expansion into the clinical development of ADCs for oncology Taiho Oncology, Inc., Taiho Pharmaceutical Co., Ltd., and Araris Biotech AG (“Araris”) today announced that the U.S. Food and Drug Administration (FDA) has completed its Investigational New Drug (IND) review period for ARC-02, an antibody-drug conjugate (ADC) being developed for the treatment of non-Hodgkin lymphoma, enabling Taiho Oncology to initiate a Phase 1 dose-escalation clinical trial of ARC-02. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260427127507/en/ Taiho Pharmaceutical acquired Araris Biotech in March 2025, expanding Taiho group’s capabilities in biologics and ADC research and development. Araris is a spin-off of the Paul Scherrer Institute and ETH in Switzerland focused on the development of antibody-drug co
Boomi To Unveil the Future Of Data Activation and AI-Driven Innovation at Boomi World 202627.4.2026 15:00:00 CEST | Press release
Premier global event to highlight how organizations are bringing data to life to power everything from AI to BI Boomi, the data activation company, today announced Boomi World 2026, its premier annual user conference, taking place May 11 - 14, 2026 in Chicago, IL. The event will bring together customers, partners, and industry leaders from around the world to explore how data activation is transforming the enterprise and accelerating the path to AI-driven outcomes. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260427600340/en/ Boomi To Unveil the Future Of Data Activation and AI-Driven Innovation at Boomi World 2026 Boomi World 2026 will spotlight data activation — bringing data to life to power AI, analytics, and intelligent automation. Attendees will gain firsthand insights into how the Boomi Enterprise Platform enables businesses to unify data, streamline operations, and innovate faster in an increasingly agentic world.
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom